ARTICLE
25 June 2025

LD Düsseldorf, June 16, 2025, Decision On Infringement, UPC_CFI_140/2024

BP
Bardehle Pagenberg

Contributor

BARDEHLE PAGENBERG combines the expertise of attorneys-at-law and patent attorneys. As one of the largest IP firms in Europe, BARDEHLE PAGENBERG advises in all fields of Intellectual Property, including all procedures before the patent and trademark offices as well as litigation before the courts through all instances.
The interpretation of a patent claim is a matter of law. The Court must independently construe the claims.
Germany Intellectual Property

1. Key takeaways

Reference to dependent claims by the parties for the first time in the oral proceedings for the interpretation of the independent claims may not be late.

The interpretation of a patent claim is a matter of law. The Court must independently construe the claims. The first reference to (further) subclaims at the oral hearing may be admissible provided that the feature in question was already in dispute and the subclaims merely provide additional arguments in support of the party's previously expressed opinion.

The description and the drawings must always be taken into account as aids to the interpreation of the claim and not only to resolve any ambiguities in the claim.

The claim is not only the starting point but also the decisive basis for determining the scope of protection (Art. 69 EPC). The interpretation of a claim does not depend solely on its precise wording in the linguistic sense. The description and drawings must also be taken into account. This does not mean, that the claim only serves as a guideline and that its subject-matter also extends to that which, after examination of the description and drawings, appears to be the protection sought by the patentee.

If several embodiments are presented in the description as being in accordance with the invention, the terms used in the claim are to be understood, in case of doubt, as meaning that all embodiments can be used to fulfil them.

The same applies for subclaims, which do not normally narrow the scope of the independent claim. They merely demonstrate possibilities for its design, which may offer an additional advantage.

2. Division

Local Division Düsseldorf

3. UPC number

UPC_CFI_140/2024

4. Type of proceedings

Infringement action

5. Parties

Claimant: 10x Genomics, Inc.

Defendant: Curio Bioscience Inc.

6. Patent(s)

EP 2 697 391 B1

7. Body of legislation / Rules

Art. 69 EPC

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More